METHODS
Accepted on 24 Jun 2025
HRS-4642 combined with nimotuzumab in the treatment of recurrent or metastatic pancreatic ductal adenocarcinoma: study protocol of a single-arm, prospective Phase Ib/II trial
doi 10.3389/fphar.2025.1562481
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Advances in targeted therapeutics for gastrointestinal cancers
Advances in targeted therapeutics for gastrointestinal cancers
693
Total downloads
4,696
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CASE REPORT
Published on 06 Jun 2025
Primary pancreas NTRK-rearranged neoplasm harboring an EVT6::NTRK3 fusion with a sclerosing epithelioid fibrosarcoma morphology: a case report and comprehensive review of the literature
doi 10.3389/fonc.2025.1526281
- 775 views
ORIGINAL RESEARCH
Published on 02 Jun 2025
SNORA13 antisense oligonucleotides enhances the therapeutical effects of 5-fluorouracil in colon adenocarcinoma
doi 10.3389/fphar.2025.1564682
- 903 views
ORIGINAL RESEARCH
Published on 29 Aug 2024
Sulforaphane regulates cell proliferation and induces apoptotic cell death mediated by ROS-cell cycle arrest in pancreatic cancer cells
doi 10.3389/fonc.2024.1442737
- 2,154 views
- 3 citations
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: